Castle Creek Arbitrage’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Castle Creek Arbitrage’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-50,000	Closed	-$590	–	375
2023 Q2	$590	Hold	50,000	–	–	﹤0.01%	381
2023 Q1	$3.13K	Hold	50,000	–	–	﹤0.01%	432
2022 Q4	$4.87K	Hold	50,000	–	–	﹤0.01%	441
2022 Q3	$11K	Hold	50,000	–	–	﹤0.01%	544
2022 Q2	$11K	Hold	50,000	–	–	﹤0.01%	578
2022 Q1	$39K	Sell	50,000 -50,000	-50%	-$36.6K	﹤0.01%	544
2021 Q4	$119K	Hold	100,000	–	–	0.01%	512
2021 Q3	$101K	Hold	100,000	–	–	0.01%	492
2021 Q2	$108K	Hold	100,000	–	–	0.01%	524
2021 Q1	$87K	Buy	+100,000	New	+$104K	0.01%	476

Castle Creek Arbitrage's GRNAW Position: Q3 2023 in Review

Castle Creek Arbitrage sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 50,000 shares — an estimated $590 sold.

Castle Creek Arbitrage first reported a position in GRNAW in Q1 2021 and held it in 10 quarters. The position peaked at $119K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

Castle Creek Arbitrage reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 50,000 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $590.
Castle Creek Arbitrage first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2021 and held it in 10 quarters.
Castle Creek Arbitrage's GreenLight Biosciences Holdings, PBC Warrant position peaked at $119K in Q4 2021.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Castle Creek Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.